MedPath

Effects of branched-chain amino acids support in patients undergoing radiofrequency ablation for hepatocellular carcinoma: a randomized controlled study

Phase 3
Conditions
hepatocellular carcinoma
Registration Number
JPRN-UMIN000003085
Lead Sponsor
Yokohama City University Medical Center Gastroenterological Center
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
80
Inclusion Criteria

Not provided

Exclusion Criteria

Exclusion criteria are the presence of any one of the following: serum albumin <2.5mg dL, serum total bilirubin level <3mg/dL, hepatic encephalopathy of or above grade II, history of albumin infusion or receiving BCAA granules in the preceding 3 months, and bleeding varices.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Short- to mid-term effects of liver function and nutrition status during the post ablative period.
Secondary Outcome Measures
NameTimeMethod
Time to tumor progression
© Copyright 2025. All Rights Reserved by MedPath